Properties
Description
Nazartinib mesylate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (L858/T790MR).
Molecular Formula
C27H35ClN6O5S
Targets
EGFR (L858/T790MR): 31 nM (Ki)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Nazartinib mesylate can be used to explore its therapeutic potential as a third-generation EGFR inhibitor.